Ecolab Launches Integrated Cooling Platform to Support AI Data Centers
ECL's new Cooling as a Service platform targets soaring AI data center demand with integrated site-to-chip efficiency upgrades.
HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience
HQY's new agentic AI is likely to provide faster, more intuitive support across channels, aiming to boost member satisfaction.
Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PODD's Q3 earnings and revenues top forecasts, with strong Omnipod growth and margin expansion lifting shares.
TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down
Teleflex posts strong Q3 earnings and revenue beats but trims 2025 outlook, sending shares slightly lower.
Is Invesco S&P MidCap 400 GARP ETF ( GRPM ) a Strong ETF Right Now?
Smart Beta ETF report for ...
ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours
Alcon posts mixed Q3 results as earnings top estimates but revenues miss. new product launches fuel optimism.
Should Invesco S&P MidCap 400 GARP ETF ( GRPM ) Be on Your Investing Radar?
Style Box ETF report for ...
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
PEN's Q3 results impress with double-digit sales growth, margin expansion and a strong 20% stock surge after its earnings beat.
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up
Veracyte surges 27.5% after Q3 earnings and revenues beat estimates, driven by strong Decipher and Afirma test growth.
BTSG vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. ( BTSG Quick QuoteBTSG - ) and Medpace ( MEDP Quick QuoteMEDP - ) . But which of these two stocks presents investors with the better value opportunity right now?
STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up
STERIS posts strong Q2 results with earnings and revenue beats, margin expansion, and a raised 2026 EPS outlook.
New Strong Buy Stocks for November 6th
MEDP, ROKU, LNC, UVV and SBFG have been added to the Zacks Rank #1 (Strong Buy) List on Nov. 6, 2025.
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop
Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.
TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours
Tempus AI reports a narrower-than-expected Q3 loss and stronger revenues, raises full-year outlook, but shares decline following the results.
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
Bio-Techne's Q1 earnings meet expectations, but revenues slip 1%, sending shares lower despite stronger margins.
CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls
Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.
HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up
Henry Schein's Q3 earnings and revenues top estimates, lifting the stock as the company raised its 2025 outlook on solid business momentum.
HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands
Hologic posts solid Q4 gains with earnings and revenue beat, margin expansion, and a buyout deal by Blackstone and TPG.
BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs
Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.
BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs
Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.
Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand
RMD's Q1 earnings and revenues top estimates as solid device and mask sales lift margins and boost investor confidence.
Major Decision: Jesse J Geiger Exercises Options, Realizing $9.62M At Medpace Hldgs - Medpace Hldgs ( NASDAQ:MEDP )
Disclosed in a recent SEC filing on October 29, Geiger, President at Medpace Hldgs ( NASDAQ:MEDP ) , made a noteworthy transaction involving the exercise of company stock options. What Happened: A Form 4 filing with the U.S.
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
BIO's Q3 earnings fall short of estimates despite higher revenues, as margin pressure and weak research demand weigh on results.
Is Medpace ( MEDP ) Stock Outpacing Its Medical Peers This Year?
Here is how Medpace (MEDP) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up
CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.
Medpace ( MEDP ) Upgraded to Strong Buy: What Does It Mean for the Stock?
Medpace (MEDP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stock to Buy for Oct. 28th
MEDP, VRT and TTWO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 28, 2025.
New Strong Buy Stocks for Oct. 28: NCNO, VRT, and More
NCNO, VRT, BFH, MEDP and MCFT have been added to the Zacks Rank #1 (Strong Buy) List on October 28, 2025.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Medpace Popped 13% This Week
The biopharmaceutical processor posted another strong earnings result for the third quarter.
Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings - Medpace Hldgs ( NASDAQ:MEDP )
Medpace Holdings Inc. ( NASDAQ:MEDP ) posted better-than-expected third-quarter earnings on Thursday. The clinical contract research organization reported earnings of $3.86, beating the consensus of $3.52. Sales reached $659.9 million, surpassing the consensus of $640.99 million.
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins Medpace Earnings Beat: Robust Growth And Large New Wins - Medpace Hldgs ( NASDAQ:MEDP )
Medpace Holdings Inc. ( NASDAQ:MEDP ) is trading higher on Thursday after the company released third-quarter earnings. The clinical contract research organization reported earnings of $3.86, beating the consensus of $3.52. Sales reached $659.9 million, surpassing the consensus of $640.99 ...
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday - Alcoa ( NYSE:AA ) , CACI International ( NYSE:CACI )
U.S. stocks were mixed, with the Dow Jones index falling around 0.1% on Thursday. Shares of Las Vegas Sands Corp. ( NYSE:LVS ) surged 11.8% to $56.64 after the company reported third-quarter EPS and sales above expectations, raised its dividend and added $2 billion to its stock buyback program.
Stock Market Today: Dow Jones, Nasdaq Futures Tumble Amid US-China Trade Tensions-Tesla, IBM, American Airlines In Focus - SPDR S&P 500 ( ARCA:SPY )
U.S. stock futures were swinging on Thursday following Wednesday's declines. Futures of major benchmark indices were lower. A wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence.
Medpace ( MEDP ) Beats Q3 Earnings and Revenue Estimates
Medpace (MEDP) delivered earnings and revenue surprises of +10.29% and +3.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
SOLV or MEDP: Which Is the Better Value Stock Right Now?
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.
Medpace ( MEDP ) Rises As Market Takes a Dip: Key Facts
Medpace (MEDP) concluded the recent trading session at $521.21, signifying a +1.34% move from its prior day's close.
Medpace ( MEDP ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace ( MEDP ) Dips More Than Broader Market: What You Should Know
Medpace (MEDP) closed the most recent trading day at $501.22, moving 3.37% from the previous trading session.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Will Medpace ( MEDP ) Beat Estimates Again in Its Next Earnings Report?
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Brookdale Posts Strong YoY Rise in September 2025 Occupancy
BKD's September weighted average consolidated occupancy rate hits 82.5%, up 330 bps YoY. The metric signals a year-over-year rise of 290 bps in third-quarter 2025.
Is Medpace ( MEDP ) Outperforming Other Medical Stocks This Year?
Here is how Medpace (MEDP) and Black Diamond (BDTX) have performed compared to their sector so far this year.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System
NYXH's first U.S. commercial use of its Genio system signals strong physician demand and sets the stage for broad adoption in sleep apnea care.
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both Solventum ( SOLV Quick QuoteSOLV - ) and Medpace ( MEDP Quick QuoteMEDP - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Medpace ( MEDP ) Stock Declines While Market Improves: Some Information for Investors
Medpace (MEDP) closed at $536.17 in the latest trading session, marking a -1.42% move from the prior day.
This RH Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Edison Intl ( NYSE:EIX ) , American Tower ( NYSE:AMT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
